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Abstract
Meal replacements are a safe and effective tool for weight loss and weight manage-
ment and beyond. Recent research and concepts suggest that the category can provide 
additional metabolic and nutritional benefits not previously recognized. Recent studies 
indicate that use of protein‐enriched meal replacements helps maintain lean body mass 
during weight loss, providing additional metabolic benefits in the form of improved 
insulin sensitivity and reduced inflammation. Depending on the formulation, meal 
replacements can have a low glycemic index and have a high nutrient density relative to 
energy density, the latter being an important aspect highlighted in government dietary 
guidance. While well defined in some markets, there is a need to establish clear regula-
tory standards in other key markets to ensure a level playing field and proper recognition 
of the category.
Keywords: meal replacement, weight loss, body composition, glycemic index, nutrient 
adequacy, regulation
1. Introduction
Globally, obesity rates remain high, and although incidence has plateaued in some countries 
(e.g., US men), rates of related comorbidities continue to escalate, such as, type II diabetes. 
Nutrition survey data suggest that populations are becoming overfed, yet undernourished, 
due to the poor nutrient density of the diet, contributing simultaneously to elevated rates of 
chronic disease and nutrient inadequacy. Meal replacements (MR)—a prepackaged, calorie‐
controlled product in a bar or powder mix that can be made into a shake or beverage—have 
long been validated as safe and effective tools for weight loss (and weight maintenance). More 
recent studies have indicated that high‐protein MR are also effective at maintaining lean body 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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mass and reducing visceral body fat during weight loss. This review focuses on MR that do 
not require medical supervision (those classified as medical foods).
Depending on the formulation, MR also possess the advantage of having a low glycemic 
index (GI) value; low‐GI diets have been linked to improved weight maintenance and reduc-
tion in risk of diabetes and ocular disease. Many nutrition researchers and authoritative bod-
ies around the world have highlighted the need to improve the nutrient density of diets as a 
means to reduce obesity while maintaining optimal nutrition status. MR also tend to be nutri-
ent dense, meaning that they possess a high ratio of essential nutrients relative to calories.
Some markets have established clear regulatory standards and definitions for the composition 
and marketing claims for MR (e.g., Codex, Canada, EU, Brazil, Korea, Indonesia). However, 
several large markets (e.g., US, Mexico, China, Russia, India) still lack these important stan-
dards, in turn limiting research opportunities and recognition by governments, healthcare 
professionals and consumers of the value the category provides.
The aim of this chapter is to review the extensive body of literature validating the safety 
and effectiveness of MR as weight loss and weight maintenance tools; explore the benefits of 
MR beyond weight loss, including maintenance of lean body mass and low glycemic index; 
discuss the concept of nutrient density, its importance in nutrition and how MR fit into a 
nutrient‐dense diet; and discuss the need for regulatory standards to be established in those 
countries that currently lack a definition for MR.
2. Meal replacements for weight loss and weight maintenance
According to the most recent global analysis, obesity rates continue to rise at an alarming level 
overall, reaching 50% of the population in some countries (Figure 1), with the prevalence in 
women rising faster than that for men. Globally, the prevalence of obesity now exceeds that 
of underweight (NCD Risk Factor Collaboration 2016). Although obesity rates in some devel-
oped countries appear to have leveled off (e.g., US men) [1], comorbidities, such as type II 
diabetes, continue to rise. The World Health Organization (WHO) estimates the prevalence 
of diabetes has doubled worldwide since 1980 and resulted in 3.7 million deaths in 2012, with 
combined direct and indirect costs estimated in the $billions annually [2]. With overweight 
and obesity recognized as the strongest risk factors for type II diabetes, the WHO recom-
mends obesity prevention, through healthy diet and physical activity, as a key approach.
Few tools have been validated as safe and effective in the treatment or prevention of obesity 
and overweight. Bariatric surgery is effective at treating those who are morbidly obese, yet 
it is associated with substantial risks and postsurgery complications, including nutrient defi-
ciency. While advances in science and technology have eventually provided several effica-
cious pharmaceutical drugs for obesity treatment, the effects are modest and associated with 
a myriad of side effects [3], and many FDA‐approved prescription weight loss drugs have 
been subsequently withdrawn from the market due to safety concerns [4]. In contrast, nearly 
150 studies demonstrate that use of MR (in various forms) safely reduces energy intake and 
results in sustainable weight loss (Table 1). A systematic review published concluded that 
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MR safely and effectively produce sustainable weight loss [5]. The systematic review included 
six randomized, controlled MR intervention studies of at least 3 months duration, involving 
adults with a body mass index (BMI) ≥ 25 kg/m2.
More recent studies have demonstrated MR effectiveness at maintaining weight loss up to sev-
eral years. Intervention studies involving MR use with a year or more of follow‐up have shown 
a range of sustained weight loss from 2% up to 11% of baseline body weight (Figure 2) [6–21].
Approach Category Effectiveness for obesity 
treatment—long term  
(>1 year)
Side and adverse effects
Pharmacological Prescription drug 5% total body weight  
(Khera 2016)
Significant and serious, 
with some drugs having 
received FDA approval, then 
subsequently withdrawn 
from the market
Bariatric surgery Medical device 30% of total body weight in 
the morbidly obese  
(Chow 2016)
High risks associated with 
surgery and postsurgery 
complications, including 
nutrient inadequacy or 
deficiency
Meal replacements Conventional food and 
medical food
7–8% total body weight 
(Heymsfield 2003)
Only nonserious (nuisance) 
effects reported
Table 1. Relative comparison between pharmacological, surgical and meal replacement approaches to obesity treatment 
and prevention.
Figure 1. World Health Organization Global Health Observatory (GHO) data. Global overweight and obesity prevalence. 
Source: World Health Organization http://www.who.int/gho/ncd/risk_factors/overweight/en/.
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Portion size is a key factor in determining energy intake and may be closely linked to obe-
sity. Research indicates that portion size is directly correlated with energy intake, suggesting 
that controlling portion size is an effective approach to reduce energy intake and combat 
obesity [22]. Among the few portion control tools researched to date, liquid MR are consid-
ered among the most effective and consistent, particularly if combined with other efforts to 
encourage consumption of high‐nutrient‐dense, low‐energy‐dense foods [22]. Furthermore, 
MR promote adherence to a restricted calorie diet due to simple preparation and convenience 
compared to preparing and cooking low‐calorie foods at home. MR generally contain a tight 
range of total calories, macro‐ and micronutrients (Figure 3), and are a nutrient‐dense tool, 
especially useful for supporting adherence to a calorie‐restricted diet through portion control.
Satiety and appetite are known to impact total energy intake, as well as food choices and 
eating behavior. Both are regulated by a combination of mechanical and endocrine effects 
ranging from the gut to the brain. With respect to diet, protein has been identified as an 
important contributor to satiety, defined as the absence of hunger between meals. Dietary 
protein can induce satiety through several mechanisms including thermic effects and induc-
tion of gut hormones such as cholecystokinin (CCK) and glucagon‐like peptide 1 (GLP‐1) and 
ghrelin [23]. Intervention studies show that increased protein intake, using protein‐enriched 
MR, is effective at increasing satiety, reducing hunger sensations, decreasing energy intake 
and facilitating weight loss in obese subjects [24, 25].
Many authoritative bodies around the world have sanctioned the use of MR for weight loss 
and control. As far back as the mid‐1980s, Codex Alimentarius recognized the use of MRs for 
Figure 2. Weight loss and maintenance from randomized controlled trials ≥1 year in duration involving meal replacement.
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weight control [26]. In 2010, the European Food Safety Authority (EFSA) concluded that MR 
are effective for both weight loss and weight maintenance [27]. Most recently, the Academy of 
Nutrition & Dietetics (AND) rated strongly the use of MR as part of a comprehensive weight 
management program [28].
3. Metabolic benefits of meal replacement
Weight loss in obese subjects during an intervention is comprised of water, fat and lean (mus-
cle) mass. The amount and extent of fat and muscle loss depend on the specific weight loss 
intervention. As lean mass determines the basal metabolic rate (BMR), the goal for any weight 
loss program is to lose fat mass, while preserving muscle mass. This helps to maintain a 
higher BMR, which in turn helps to maintain energy expenditure, which can often decline 
with weight loss. Use of protein‐enriched MR products has been shown to effectively main-
tain lean body mass during weight loss [24, 29], particularly when combined with resistance 
exercise [30].
Glycemic index (GI) represents a measure of the ability or rapidity of a given food to raise 
an individual's postprandial blood glucose level. GI is determined for a given food in refer-
ence to a standard food, usually white bread, and reflects the blood glucose‐raising ability of 
digestible carbohydrates in a given food [31]. Examples of relative GI values of different foods 
can be found in Table 2.
A growing body of evidence suggests that the GI and glycemic load (GL, a measure of how 
much a given food will raise an individual's blood glucose level following consumption) of 
the diet play an important role in human metabolic functions and health. High GI foods and a 
Figure 3. General macro‐ and micronutrient composition of meal replacement products.
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high GL stimulate a rapid rise in insulin levels, which on a chronic basis can result in insulin 
resistance [32, 33]. The GL of a food is calculated by multiplying its GI by the amount of car-
bohydrate it contains per serving, and then dividing by 100. GL is a function of the amount of 
carbohydrate intake and the GI of the food. In contrast, GI is an inherent property of a food, 
independent of the amount of carbohydrate ingested. The GI value of a diet can impact insulin 
sensitivity and glucose metabolism [34]. Blood sugar levels have also been implicated in appe-
tite control, suggesting that. Furthermore, MR promote adherence to a restricted calorie diet 
due to simple preparation and convenience compared to preparing and cooking low‐calorie 
foods at home. The GI of a diet may impact overall food and energy intake [35]. Accordingly, 
low‐GI diets have been shown to be an effective approach for managing diabetes [36, 37] and 
obesity [38, 39]. The combination of a high‐protein, low‐GI diet in obese subjects is effective 
at inducing weight loss and maintenance of lean body mass [25, 36, 40]. Although it varies by 
formulation, MR tend to be high in protein and have a low GI (<55), making them ideal for 
incorporation into an overall low‐GI diet plan.
As with insulin sensitivity, the degree of intrabdominal and visceral fat is tightly linked to 
metabolic syndrome. Surrounding the body's critical organs, such as the heart and liver, vis-
ceral fat stimulates systemic inflammation and is known as an increasingly serious risk fac-
tor for chronic diseases, including cardiovascular disease and diabetes [41]. In simple terms, 
“sarcopenic obesity” can be defined as low skeletal muscle mass and strength combined with 
excess body fat, much of which is visceral fat [42, 43]. The concept has also been described 
as “thin outside, fat inside” or “TOFI” [44]. Related to obesity, individuals can have the 
same body mass index (BMI), but vastly different inflammatory states and risk levels due to 
Table 2. Glycemic index (GI) values of select foods.
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 differences in distribution and degree of visceral fat [45]. As there is as yet no medical cure, 
resistance and strength exercise, combined with a high‐protein diet, is recommended as one 
of the only effective means of addressing sarcopenic obesity and complications of excess vis-
ceral fat [30, 46]. When used in conjunction with reduced total calorie intake and resistance 
exercise, MR can also be effective at reducing visceral fat [19, 30, 47].
With respect to safety, use of MR for weight control and other metabolic benefits is among the 
safest approaches studied. Many individual intervention studies [48–50] as well as systematic 
reviews [51] have confirmed that MR safely facilitate weight loss and maintenance.
4. Meal replacements and nutritional adequace
According to the 2015 Dietary Guidelines for Americans, individuals should consume more 
nutrient‐dense foods to better balance meeting nutritional needs while avoiding excess calo-
ries or energy [52]. A position paper from the Academy of Nutrition & Dietetics concluded 
that there is a positive association between dietary energy density and increased adiposity 
[53]. Nutrient density is a term referring to the amount of essential nutrients in a food relative 
to the amount of energy (calories) that food delivers. High‐nutrient‐dense foods provide a 
high level of nutrients with relatively low caloric value, and low‐nutrient‐dense foods pro-
vide a high level of calories with relatively low nutrient content [54, 55]. Examples of nutri-
ent‐dense foods include fruits, vegetables, whole grains, lean meats and dairy.
In the United States, more than half of the population fails to achieve the recommended intakes 
for key nutrients, including vitamins A, C, D and E, fiber, magnesium and potassium [56], all 
of which have been deemed “nutrients of concern” or “shortfall nutrients” by the 2015 Dietary 
Guidelines Advisory Committee [57]. Incorporation of more nutrient‐dense foods into the diet 
is an effective approach to achieve proper nutrient adequacy without adding excess calories.
Overweight and obese individuals are at even higher risk than the general population of expe-
riencing nutrient deficiency, particularly vitamin D [58]. This is believed to be due, in part, 
to overconsumption of a high‐energy‐dense and low‐nutrient‐dense diet [59], a phenomenon 
described as “overfed but undernourished” [60]. Furthermore, weight loss regimens, particu-
larly those involving rapid weight loss, can lead to compromised nutritional status [61].
With a modest amount of calories, added essential vitamins, minerals and fiber, MR are consid-
ered to be a nutrient‐dense food. Indeed, a variety of studies demonstrates that use of MR dur-
ing a weight control regimen helps to ensure adequate intake of essential nutrients [12, 62–64].
5. Meal replacement definitions and standards
In some markets around the world, regulations exist to define MR, both in function and in 
composition. The definition, specific authorized claims for weight loss or management and 
 composition standards (for both macro‐ and micronutrients) vary by country (Table 3). The 
Codex Alimentarius composition standards for MR were established back in 1991 and have 
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served as the basis for the definition in a number of other markets [65]. Establishing regulations 
and composition standards has served as the basis for sanctioning weight loss benefit claims 
for MR and has facilitated harmonization in multi‐country regions (e.g., EU). Together with 
the plethora of data supporting the safety and efficacy of MR, these standards have also led to 
increased use, research and acceptance of MR by the healthcare professional community [66].
However, in other markets with high obesity prevalence, including the United States, Mexico, 
China and Russia, no such standards have been established. The reasons for the lack of MR 
Codex Australia Brazil Canada Chile EU Indonesia Korea US & 
China
Energy 200–400 kcal ≥200 kcal ≥200–400 kcal
≥225 kcal ≥200–400 
kcal
200–250 
kcal
≥200 kcal ≥200–400 
kcal
None
Protein 25–50% of 
total energy; 
≤125 g/day
≥12 g 25–50% 
energy of 
product  
and <125 g
20–40% 
energy of 
product
25–50% 
energy of 
product  
and <125 g
25–50% 
energy of 
product
≥12 g ≥10% NRV None
Fat ≤30% of total 
energy
None ≤30% 
energy of 
product
≤35% energy 
of product
≤30% 
energy of 
product
≤30% 
energy of 
product
≤13 g None None
Fat from 
linoleic 
acid
≥3% of total 
energy of 
linoleic acid 
(glycderide 
form)
None ≥3% energy 
of product
≥3% energy 
of product
≥3% energy 
of product
≥1 g None None None
Linoleic 
acid & 
linolenic 
acid ratio
None None None 4:1–10:1 None None None None None
Vitamin 33–25% of 
specified 
amount 
in Codex 
181‐1991 
(depend on # 
of servings/
day)
Specific 
minimum 
indicated
Specific 
minimum 
indicated
Specific 
minimum 
indicated
Specific 
minimum 
indicated
≥30% NRV ≥25% RDA ≥25% NRV None
Mineral 33–25% of 
specified 
amount 
in Codex 
181‐1991 
(depend on # 
of servings/
day)
Specific 
minimum 
indicated
Specific 
minimum 
indicated
Specific 
minimum 
indicated
Specific 
minimum 
indicated
≥30% NRV 
w/ specific 
limit on 
Na & K No 
min limit: 
F, Cr, Cl, 
Mo
≥25% RDA ≥25% NRV None
Essential 
amino 
acids
None None None None None Yes—
profile 
WHO 1985
None None None
Table 3. Comparison of standards and regulations for meal replacements in various markets around the world.
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regulations and standards in these countries vary, but are tied closely to the existing food 
and/or dietary supplement policy and regulatory framework. For example, in the United 
States, composition or identity standards are not expressly required in order for products 
to bear health benefit claims. For MR, as with conventional foods and dietary supplements, 
the ability to bear a weight loss claim is predicated on the availability, quality and quantity 
of scientific substantiation, not a formal definition for MR or composition standards [67]. In 
contrast, in the case of Mexico, MR are regulated under the category of food supplements. By 
regulation, food supplements are not permitted to bear claims of any kind [68], thus eliminat-
ing the ability to communicate a weight loss benefit for the category and reducing the need to 
establish a definition. Finally, in China, MR are regulated under the health or functional food 
category [69]. Products in this category are required to go through animal and/or human test-
ing (depending on the desired claim) as part of a premarket registration process. This testing 
requirement to validate the health food product prior to market has precluded the need for a 
specific MR definition or standard.
Establishing full recognition of the health benefits of MR in these markets may ultimately require 
a formal definition and composition standards. Indeed, the absence of a formal regulation for 
MR has allowed the category to be inappropriately targeted with antiobesity policies aimed at, 
for example, curbing the public's consumption of sugars. In Mexico, MR are subject to the same 
tax aimed at reducing intake of sodas and other sugar‐sweetened beverages as part of a broader 
public health initiative [70]. In the United States, similar policy has been proposed at both the 
Federal [71, 72] and state levels [73] and has passed at the local level [72, 74]. In some cases, MR 
have been exempted (Berkley, CA), and in others, this exemption has not been expressly granted 
(Philadelphia). Imposing such policy on MR seems incongruent with the state of the evidence, 
which clearly demonstrates that MR are part of the obesity solution, not the problem.
The absence of a formal definition for MR may negatively impact the consumer, as products 
claiming to be a MR may not meet basic compositional expectations. Consumers conceiv-
ably stand to benefit from a standard or regulation by receiving properly formulated and 
consistent products. The absence of a formal definition has also prevented the category from 
being included in potentially beneficial public policy aimed at obesity and disease preven-
tion. Without a clear standard of identity and recognition of its health benefits, MR cannot be 
included in government‐sponsored programs such as Flexible Savings Accounts or Health 
Savings Accounts.
6. Summary and conclusions
Rates of obesity and comorbidities continue to rise worldwide. MR are among the safest most 
effective tools available demonstrating significant and long‐term weight loss. MR use pro-
vides benefits well beyond weight loss, including body composition and metabolic benefits 
from its low glycemic index. As a nutrient‐dense food, MR are also effective at achieving and 
maintaining nutrient adequacy without delivering excess calories. Although well defined in 
some markets, MR still lack a formal definition and regulation in several key markets around 
the world. The absence of this formal recognition and composition standards has left the cat-
egory vulnerable to onerous public policy while being excluded from potentially beneficial 
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policy. Efforts to establish formal regulations in these key markets should be considered in 
order for the category to provide its full impact on obesity and public health.
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